InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,229.45
(
0.13%
)
US TECH 100
17,716.00
(
0.19%
)
Dow Jones
39,605.18
(
0.23%
)
Brent Oil
83.35
(
1.17%
)
Bitcoin
62,975.82
(
2.50%
)
Post# of 43747
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

alexander77

Send PM Follow Ignore
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

alexander77

Re: The_Q post# 18933

Thursday, 03/14/2019 1:47:20 AM

Thursday, March 14, 2019 1:47:20 AM

Post# of 43747
During the latest presentation it was clearly stated that Keytruda or Opdivo have NOT been used in the P3 trial of Multikine!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CVM News
More CVM News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!